Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis

Adnan Agha, Mamdouh M Abdulhadi, Simona Marenco, Abdelhaleem Bella, Dib Alsaudi, Ahmed El-Haddad, Simona Inferrera, Vincenzo Savarino, Edoardo G Giannini, Adnan Agha, Mamdouh M Abdulhadi, Simona Marenco, Abdelhaleem Bella, Dib Alsaudi, Ahmed El-Haddad, Simona Inferrera, Vincenzo Savarino, Edoardo G Giannini

Abstract

Background/aim: In patients with liver cirrhosis, the platelet count/spleen diameter ratio has been validated as a parameter for the noninvasive diagnosis of esophageal varices. Schistosoma infection is a frequent cause of portal hypertension in Middle Eastern countries, and is associated with the development of esophageal varices. In this study we aimed to evaluate the platelet count/spleen diameter ratio as a noninvasive tool for the prediction of the presence of esophageal varices in patients with schistosoma-related chronic liver disease.

Patients and methods: Forty-three patients with hepatosplenic schistosomiasis underwent upper digestive endoscopy to check for the presence of esophageal varices. Furthermore, all patients underwent abdominal ultrasonography, and maximum spleen diameter (in mm) was measured. The platelet count/spleen diameter ratio was calculated in all patients.

Results: Esophageal varices were found in 31 patients (72%). Age and gender were not significantly different between patients with and without varices. In patients with varices, median platelet count (82,000/μL versus 172,000/μL, P < 0.0001) and platelet count/spleen diameter ratio (571 versus 1651, P < 0.0001) were significantly lower, while spleen diameter (147 mm versus 109 mm, P = 0.0006) was significantly larger. In multivariate analysis, the platelet count/spleen diameter ratio was the only parameter independently associated with the presence of varices (P < 0.0001).

Conclusions: In this study we have validated the use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with portal hypertension caused by schistosoma infection. In these patients, the platelet count/spleen diameter ratio might be used to allow better rationalization of medical resources and use of endoscopy.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Receiver operating characteristics’ curves showing the platelet count/spleen diameter ratio cutoff with the best diagnostic accuracy on the basis of the presence of esophageal varices

References

    1. Chitsulo L, Engels D, Montresor A, Savioli L. The global status of schistosomiasis and its control. Acta Trop. 2000;77:41–51.
    1. Da Silva LC, Chieffi PP, Carrilho FJ. Schistosomiasis mansoni- Clinical features. Gastroenterol Hepatol. 2005;28:30–9.
    1. Manzella A, Ohtomo K, Monzawa S, Lim JH. Schistosomiasis of the liver. Abdom Imaging. 2008;33:144–50.
    1. De Franchis R, Dell’Era A, Primignani M. Diagnosis and monitoring of portal hypertension. Dig Liver Dis. 2008;40:312–7.
    1. Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee. Am J Gastroenterol. 1997;92:1081–91.
    1. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: A meta-analytic review. Hepatology. 1995;22:332–54.
    1. Martin RD, Szejnfeld J, Lima FG, Ferrari AP. Endoscopic, ultrasonographic, and US-Doppler parameters as indicators of variceal bleeding in patients with schistosomiasis. Dig Dis Sci. 2000;45:1013–8.
    1. De Franchis R. Evolving consensus in portal hypertension report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–76.
    1. Spiegel BM, Targownik L, Dulai GS, Karsan HA, Gralnek IM. Endoscopic screening for esophageal varices in cirrhosis. Is it ever cost effective? Hepatology. 2003;37:366–77.
    1. Arguedas MR, Heudebert GR, Eloubeidi MA, Abrams GA, Fallon MB. Cost-effectiveness of screening, surveillance and primary prophylaxis strategies for esophageal varices. Am J Gastroenterol. 2002;97:2441–52.
    1. Amico GD, Morabito A. Noninvasive markers of esophageal varices: Another round, not the last. Hepatology. 2004;39:30–4.
    1. Pilette C, Oberti F, Aubè C, Rousselet MC, Bedossa P, Gallois Y, et al. Non-invasive diagnosis of esophageal varices in chronic liver disease. J Hepatol. 1999;31:867–73.
    1. Madhotra R, Mulcahy HE, Willner I, Reuben A. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2002;34:81–5.
    1. Thomopoulos KC, Labropoulou KC, Mimidis KP, Katsakoulis EC, Iconomou G, Nikolopoulou VN. Non-invasive predictors of the presence of large esophageal varices in patients with cirrhosis. Dig Liver Dis. 2003;35:473–8.
    1. Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, et al. Platelet count/spleen diameter ratio: Proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003;52:1200–5.
    1. Giannini E, Botta F, Borro P, Dulbecco P, Testa E, Mansi C, et al. Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: A validation study based on follow-up. Dig Liver Dis. 2005;37:779–85.
    1. Zimbwa TA, Blanshard C, Subramaniam A. Platelet count/spleen diameter ratio as a predictor of oesophageal varices in alcoholic cirrhosis. Gut. 2004;53:1055.
    1. Baig WW, Nagaraja MV, Varma M, Prabhu R. Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: Is it feasible? Can J Gastroenterol. 2008;22:825–8.
    1. Agha A, Anwar A, Bashir K, Savarino E, Giannini EG. External Validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci. 2009;54:654–60.
    1. Cammà C, Petta S, Di Marco V, Bronte F, Ciminnisi S, Licata G, et al. Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Hepatology. 2009;49:195–203.
    1. Sarangapani A, Shanmugam C, Kayanasundaram M, Rangachari B, Thangavelu P, Subbarayan JK. Noninvasive prediction of large esophageal varices in chronic liver disease patients. Saudi J Gastroenterol. 2010;16:38–42.
    1. De Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol. 1992;15:256–61.
    1. Alempijevic T, Bulat V, Djuranovic S, Kovacevic N, Jesic R, Tomic D, et al. Right liver lobe/albumin ratio: Contribution to non-invasive assessment of portal hypertension. World J Gastroenterol. 2007;13:5331–5.
    1. Harrell FE, Jr, Lee KL, Mark BD. Tutorial in biostatistics.Multivariable prognostic models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–87.
    1. Hanley JA, McNeil BJ. The meaning and use of the area under receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.
    1. Rebouças G. Clinical aspects of hepatosplenic schistosomiasis: A contrast with cirrhosis. Yale J Biol Med. 1975;48:369–76.
    1. De Cock KM, Awadh S, Raja RS, Wankya BM, Lucas SB. Esophageal varices in Nairobi, Kenya: A study of 68 cases. Am J Trop Med Hyg. 1982;31:579–88.
    1. Davidson RN, Houston S, Kiire CF. Schistosomal periportal fibrosis in Zimbabwe: Use of ultrasound in patients with oesophageal varices. Trans R Soc Trop Med Hyg. 1991;85:380–2.
    1. Domingues AL, Lima AR, Dias HS, Leao GC, Coutinho A. An ultrasonographic study of liver fibrosis in patients infected with Schistosoma mansoni in north-east Brazil. Trans R Soc Trop Med Hyg. 1993;87:555–8.
    1. Nash TE, Cheever AW, Ottesen EA, Cook JA. Schistosome infections in humans: Perspectives and recent findings.NIH conference. Ann Intern Med. 1982;97:740–54.
    1. Saad AM, Homeida M, Eltom I, Nash T, Bennett JL, Hassan MA. Oesophageal varices in a region of the Sudan endemic for Schistosoma mansoni. Br J Surg. 1991;78:1252–3.
    1. O’Donohue J, Ng C, Catnach S, Farrant P, Williams R. Diagnostic value of Doppler assessment of the hepatic and portal vessels and ultrasound of the spleen in liver disease. Eur J Gastroenterol Hepatol. 2004;16:147–55.
    1. Winkfield B, Aubé C, Burtin P, Calès P. Inter-observer and intra-observer variability in hepatology. Eur J Gastroenterol Hepatol. 2003;15:959–66.
    1. Farias AQ, Kassab F, da Rocha EC, Dos Santos Bomfim V, Vezozzo DC, Bittencourt PL, et al. Propranolol reduces variceal pressure and wall tension in schistosomiasis presinusoidal portal hypertension. J Gastroenterol Hepatol. 2009;24:1852–6.
    1. Tanabe M. Haemostatic abnormalities in hepatosplenic schistosomiasis mansoni. Parasitol Int. 2003;52:351–9.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe